Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation

Hepatosplenic γδ T-cell lymphoma (HSTCL) is a rare aggressive peripheral T-cell lymphoma. Prognosis is usually poor with a median survival between 8 and 16 months after traditional chemotherapy. Stem cell transplantation (SCT) is promising and with a more intense induction regimen, has yielded posit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Kai, Sanchez, Cesar Gentille, Pingali, Sai Ravi, Iyer, Swaminathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214677/
https://www.ncbi.nlm.nih.gov/pubmed/30483352
http://dx.doi.org/10.3332/ecancer.2018.872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214677/
https://www.ncbi.nlm.nih.gov/pubmed/30483352
http://dx.doi.org/10.3332/ecancer.2018.872

Ejemplares similares